Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L. Lin, Kelli M. Wilson, Michele Ceribelli, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 519
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse, et al.
Cancer Cell (2021) Vol. 39, Iss. 4, pp. 566-579.e7
Open Access | Times Cited: 151
Glioma
Michael Weller, Patrick Y. Wen, Susan M. Chang, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 113
Spatially controlled construction of assembloids using bioprinting
Julien G. Roth, Lucia G. Brunel, Michelle S. Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
Aaminah Khan, Laura D. Gamble, Dannielle Upton, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 96
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z. Chen, Paul Shinn, Zina Itkin, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 87
Targeting post-translational histone modifying enzymes in glioblastoma
Elena Kunadis, Eleftheria Lakiotaki, Penelope Korkolopoulou, et al.
Pharmacology & Therapeutics (2020) Vol. 220, pp. 107721-107721
Closed Access | Times Cited: 83
Functionalized Macrophage Exosomes with Panobinostat and PPM1D‐siRNA for Diffuse Intrinsic Pontine Gliomas Therapy
Shaobo Shan, Junge Chen, Yu Sun, et al.
Advanced Science (2022) Vol. 9, Iss. 21
Open Access | Times Cited: 67
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Izac J. Findlay, Geoffry N. De Iuliis, Ryan J. Duchatel, et al.
Oncogene (2021) Vol. 41, Iss. 4, pp. 461-475
Open Access | Times Cited: 59
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update
Erica A. Power, Julian S. Rechberger, Sumit Gupta, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114303-114303
Open Access | Times Cited: 39
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
Michelle Monje, Tabitha Cooney, John Glod, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 12, pp. 2262-2272
Open Access | Times Cited: 24
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma
Sabine Mueller, Cassie Kline, Schuyler Stoller, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 11, pp. 2074-2086
Closed Access | Times Cited: 23
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
Patrick Roth, Thierry Gorlia, Jaap C. Reijneveld, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 9, pp. 1670-1682
Open Access | Times Cited: 10
IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
Arnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1185-1201.e14
Closed Access | Times Cited: 8
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Julian S. Rechberger, Stephanie Toll, Subhasree Biswas, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 439-439
Open Access | Times Cited: 1
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models
Nicholas A. Vitanza, Matthew C. Biery, Carrie Myers, et al.
Neuro-Oncology (2020) Vol. 23, Iss. 3, pp. 376-386
Open Access | Times Cited: 57
MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma
Joji Ishida, Saira Alli, Andrew Bondoc, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 1034-1045
Closed Access | Times Cited: 52
Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin
Jie Li, Huamin Zeng, Yu You, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 51
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
Emmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 7, pp. 1150-1163
Open Access | Times Cited: 51
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L. Shaffer, James D. Phelan, James Q. Wang, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 6, pp. 630-647
Open Access | Times Cited: 47
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
Chen He, Ke Xu, Xiaoyan Zhu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Pooja Panwalkar, Benita Tamrazi, Derek Dang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 614
Open Access | Times Cited: 42
AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer
Tzu‐Ting Huang, Chih-Yuan Chiang, Jayakumar R. Nair, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 887-904
Closed Access | Times Cited: 7
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, et al.
Cancer Letters (2024) Vol. 590, pp. 216876-216876
Closed Access | Times Cited: 7
Cardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies
Jee Myung Yang, Se Yong Jung, Min Seo Kim, et al.
Ophthalmology (2024)
Closed Access | Times Cited: 7
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Jae‐Woo Choi, Michele Ceribelli, James D. Phelan, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 833-849.e12
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top